Waldencast (WALD)
Nasdaq Market Open
Waldencast plc is a beauty and wellness company built around a portfolio operating model. It owns and develops consumer brands in skincare, cosmetics, and personal care, with its business currently organized around two reportable segments: Obagi Skincare and Milk Makeup.
Obagi is the company’s larger revenue contributor and focuses on skin health products. The brand is known for physician-dispensed and professional skincare lines, including products aimed at concerns such as aging, hyperpigmentation, texture, and overall skin appearance. This segment gives Waldencast exposure to the premium and medical-aesthetics-adjacent skincare market, where brand credibility, clinical positioning, and professional channel relationships can be important differentiators.
Milk Makeup gives Waldencast a separate presence in color cosmetics, skincare, and beauty products aimed at a contemporary consumer audience. The brand is associated with accessible, trend-aware products and a strong identity in modern beauty retail. Together, Obagi and Milk Makeup provide Waldencast with a mix of dermatologist-oriented skincare and lifestyle-driven cosmetics, spanning different customer segments and purchase occasions.
The company generates most of its revenue in North America, although beauty brands of this type often have opportunities to expand through international distribution, digital commerce, and specialty retail partnerships. Waldencast’s strategy is to operate and scale brands rather than function as a single-product company. Its distinctive feature is the combination of established skincare assets with a consumer cosmetics brand under one listed platform focused on long-term beauty and wellness category growth.
Last updated
- Market Cap
- 239.85M
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- 240.26M
- Sector
- Materials
- Industry
- Perfumes, Cosmetics, and Other Toilet Preparations
- Address
- 10 BANK STREET, SUITE 560, WHITE PLAINS, NY, 10606
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
Waldencast Announces Participation in the 2025 IMCAS World Congress
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
Waldencast Announces Participation in Upcoming Investor Conferences
Waldencast Reports Q1 2024 Financial Results
Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast
Waldencast Announces Participation in CreatorIQ Connect Europe
Waldencast Reports Fiscal Year 2023 Financial Results
Waldencast Regains Compliance with Nasdaq Filing Requirements
Waldencast Reports First Half 2023 Results
Waldencast Receives Positive Nasdaq Listing Determination
Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors
Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
Waldencast Announces Participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit
Waldencast Names Manuel Manfredi as Chief Financial Officer
Waldencast plc Announces Fiscal Year 2022 Financial Results
Waldencast plc Announces Receipt of Anticipated Nasdaq Delinquency Notice
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 239.85M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 240.26M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- -6.85
- P/S
P/S ratio compares a company's share price to its revenue per share.
- —
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -18.45
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- —
- EPS
- -0.08
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 29.21%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -2.95%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -0.04
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.71
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.71
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.62
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 2.21M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 1.87
Income Statement
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2022 Q1 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | -4M |
| EBITDA | 0 | 0 | 0 | 0 | -4M |
| Net income | — | — | — | — | 3.02M |
| Basic EPS | — | — | — | — | 0.07 |
| Diluted EPS | — | — | — | — | 0.07 |
Balance Sheet
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2022 Q1 |
|---|---|---|---|---|---|
| Total assets | 746.16M | 975.86M | 1.04B | 1.09B | 346.31M |
| Total liabilities | 246.06M | 245.92M | 273.44M | 290.18M | 36.3M |
| Total equity | 500.1M | 729.94M | 769.27M | 799.9M | -34.99M |
| Cash & equivalents | 30.38M | 14.8M | 21.09M | 8.69M | 1.09M |
| Current assets | 125.43M | 102.12M | 105.84M | 89.57M | 1.25M |
| Current liabilities | 74.55M | 76.89M | 62.71M | 72.51M | 1.77M |
Cash Flow
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2022 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | — | — | — | — | -414.79K |
| Investing cash flow | — | — | — | — | 0 |
| Financing cash flow | — | — | — | — | 0 |
| Change in cash | — | — | — | — | -414.79K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| edgar index | 3 — Waldencast plc | View Filing | |
| form 3 | Form 3 — Brookie Kelly | View Filing | |
| form 3 | Form 3 — Sebti Hind | View Filing | |
| form 3 | Form 3 — Sebti Hind | View Filing | |
| form 3 | Form 3 — Sebti Hind | View Filing | |
| form 3 | Form 3 — Hickman Juliette | View Filing | |
| form 3 | Form 3 — Hickman Juliette | View Filing | |
| form 3 | Form 3 — Manfredi Manuel | View Filing | |
| form 3 | Form 3 — Manfredi Manuel | View Filing | |
| form 3 | Form 3 — Chatterley Aaron | View Filing | |
| form 3 | Form 3 — Chatterley Aaron | View Filing | |
| form 3 | Form 3 — Thompson Motta Roberto Moses | View Filing | |
| form 3 | Form 3 — Thompson Motta Roberto Moses | View Filing | |
| form 3 | Form 3 — Souza Cristiano | View Filing | |
| form 3 | Form 3 — Souza Cristiano | View Filing | |
| form 3 | Form 3 — Souza Cristiano | View Filing | |
| form 3 | Form 3 — Brousset Michel | View Filing | |
| form 3 | Form 3 — Brousset Michel | View Filing | |
| form 3 | Form 3 — Brousset Michel | View Filing | |
| form 3 | Form 3 — Brousset Michel | View Filing | |
| form 3 | Form 3 — Brousset Michel | View Filing | |
| form 3 | Form 3 — Brousset Michel | View Filing | |
| edgar index | 20-F — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 424B3 — Waldencast plc | View Filing | |
| edgar index | EFFECT — Waldencast plc | View Filing | |
| edgar index | F-3 — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | SCHEDULE 13G — Waldencast plc | View Filing | |
| edgar index | UPLOAD — Waldencast plc | View Filing | |
| edgar index | CORRESP — Waldencast plc | View Filing | |
| edgar index | SCHEDULE 13G/A — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | SCHEDULE 13D/A — Waldencast plc | View Filing | |
| edgar index | CORRESP — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | UPLOAD — Waldencast plc | View Filing | |
| edgar index | SCHEDULE 13G — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 20-F — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | SCHEDULE 13D/A — Waldencast plc | View Filing | |
| edgar index | 144 — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 20-F/A — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 144 — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 6-K — Waldencast plc | View Filing | |
| edgar index | 424B3 — Waldencast plc | View Filing | |
| edgar index | EFFECT — Waldencast plc | View Filing | |
| edgar index | CORRESP — Waldencast plc | View Filing |